Diabetes and Tuberculosis

Taehoon Lee

doi:10.4093/jkd.2017.18.1.32

Journal List > J Korean Diabetes > v.18(1) > 1055081

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Lee: Diabetes and Tuberculosis

Focused Issue

The Journal of Korean Diabetes 2017; 18(1): 32-36.

Published online: 28 March 2017

DOI: https://doi.org/10.4093/jkd.2017.18.1.32

Diabetes and Tuberculosis

Taehoon Lee

Division of Pulmonology, Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.

Corresponding author: Taehoon Lee. Division of Pulmonology, Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, 877 Bangeojinsunhwan-doro, Dong-gu, Ulsan 44033, Korea, ddol1996@hanmail.net

Received 10 January 2017 Accepted 1 February 2017

(open-access):

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Tuberculosis is still one of the major diseases in Korea. Recently, the number of tuberculosis patients with diabetes is increasing due to the increase in diabetes mellitus prevalence. Patients diagnosed with tuberculosis need a screening test for diabetes, and if diagnosed with diabetes, integrated management is needed. It is not yet strongly recommended to perform latent tuberculosis testing in people diagnosed with diabetes, for this, additional research is needed. In diabetic patients with tuberculosis, strict blood glucose control is needed, tuberculosis treatment could be prolonged, and insulin and metformin, which have no drug interaction with rifampin, are preferred.

Keywords: Diabetes mellitus, Tuberculosis

Figures and Tables

Table 1

Risk factors for the development of active tuberculosis (TB) among persons infected with Mycobacterium tuberculosis

Adapted from Canadian tuberculosis standards. 6th ed. Ottawa: Public Health Agency of Canada; 2007 [6].

References

1. Joint Committee for the Revision of Korean Guidelines for Tuberculosis Korea Centers for Disease Control and Prevention. Korean guidelines for tuberculosis, 2014. 2nd ed. Seoul: The Korean Academy of Tuberculosis and Respiratory Diseases;2014.

2. Ma Z, Lienhardt C, McIlleron H, Nunn AJ, Wang X. Global tuberculosis drug development pipeline: the need and the reality. Lancet. 2010; 375:2100–2109.

3. World Health Organization. Global tuberculosis report. Geneva: World Health Organization;2015.

4. Centers for Disease Control and Prevention. Korean Guidelines for Tuberculosis. Cheongju: Centers for Disease Control and Prevention;2016.

5. Nunes-Alves C, Booty MG, Carpenter SM, Jayaraman P, Rothchild AC, Behar SM. In search of a new paradigm for protective immunity to TB. Nat Rev Microbiol. 2014; 12:289–299.

6. Long R, Ellis E, Elwood K. Public Health Agency of Canada. Canada Lung Association. Canadian tuberculosis standards. 6th ed. Ottawa: Public Health Agency of Canada;2007.

7. World Health Organization. Guidelines on the management of latent tuberculosis infection. Geneva: World Health Organization;2015.

8. World Health Organization. Collaborative framework for care and control of tuberculosis and diabetes. Geneva: World Health Organization;2011.

9. Kapur A, Harries AD, Lönnroth K, Wilson P, Sulistyowati LS. Diabetes and tuberculosis co-epidemic: the Bali Declaration. Lancet Diabetes Endocrinol. 2016; 4:8–10.

10. Riza AL, Pearson F, Ugarte-Gil C, Alisjahbana B, van de Vijver S, Panduru NM, Hill PC, Ruslami R, Moore D, Aarnoutse R, Critchley JA, van Crevel R. Clinical management of concurrent diabetes and tuberculosis and the implications for patient services. Lancet Diabetes Endocrinol. 2014; 2:740–753.

11. Pizzol D, Di Gennaro F, Chhaganlal KD, Fabrizio C, Monno L, Putoto G, Saracino A. Tuberculosis and diabetes: current state and future perspectives. Trop Med Int Health. 2016; 21:694–702.

12. Chang JT, Dou HY, Yen CL, Wu YH, Huang RM, Lin HJ, Su IJ, Shieh CC. Effect of type 2 diabetes mellitus on the clinical severity and treatment outcome in patients with pulmonary tuberculosis: a potential role in the emergence of multidrug-resistance. J Formos Med Assoc. 2011; 110:372–381.

TOOLS

Similar articles